Klp Kapitalforvaltning As Lexicon Pharmaceuticals, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 26,200 shares of LXRX stock, worth $19,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,200Holding current value
$19,650% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
140Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$102 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$29.2 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$8.27 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.42 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.41 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $142M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...